SAB Biotherapeutics (SABS)
NASDAQ:SABS
Want to see SABS full AI Analyst Report?
SAB Biotherapeutics (SABS) Ownership Overview
17.39% Insiders
3.41% Mutual Funds
68.17% Other Institutional Investors
3.52% ETFs
7.52% Public Companies and
Individual Investors
The ownership structure of SAB Biotherapeutics (SABS) stock is a mix of institutional, retail, and individual investors. Approximately 75.09% of the company’s stock is owned by Institutional Investors, 17.39% is owned by Insiders, and 7.52% is owned by Public Companies and Individual Investors.
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
Dec 31, 2023 | xxxxxxxxxxxxx | $10922360 | |
Dec 31, 2023 | xxxxxxxxxxxxx | $24633576 | |
Dec 31, 2023 | xxxxxxxxxxxxx | $3294451 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 6,431,743 | Institution | 8.41% | 21,867,926 | |
| 5,232,304 | Insider | 6.84% | 17,789,834 | |
| 4,401,500 | Institution | 5.76% | 14,965,100 | |
| 2,857,142 | Insider | 3.74% | 9,714,283 | |
| 2,851,791 | Institution | 3.73% | 9,696,089 | |
| 2,428,287 | Institution | 3.18% | 8,256,176 | |
| 2,428,287 | Institution | 3.18% | 8,256,176 | |
| 2,198,457 | Insider | 2.88% | 7,474,754 | |
| 2,198,457 | Insider | 2.88% | 7,474,754 | |
| 860,170 | Institution | 1.12% | 2,924,578 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 2,428,287 | Institution | 3.18% | 8,256,176 | |
| 102,912 | Institution | 0.13% | 349,901 | |
| 37,595 | Institution | 0.05% | 127,823 | |
| 27,855 | Institution | 0.04% | 94,707 | |
| 7,265 | Institution | <0.01% | 24,701 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 2,123,393 | Institution | 2.78% | 7,941,490 | |
| 304,894 | Institution | 0.40% | 1,140,304 | |
| 187,230 | Institution | 0.24% | 636,582 | |
| 72,596 | Institution | 0.09% | 246,826 | |
| 379 | Institution | <0.01% | 1,786 |
FAQ
Who Owns SAB Biotherapeutics (SABS)?
According to the latest TipRanks data, approximately 68.17% of the company's stock is held by institutional investors, 17.39% is held by insiders, and 7.52% is held by retail investors.
What percentage of SAB Biotherapeutics (SABS) stock is held by institutional investors?
According to the latest TipRanks data, approximately 68.17% of SAB Biotherapeutics (SABS) stock is held by institutional investors.
What percentage of SAB Biotherapeutics (SABS) stock is held by retail investors?
According to the latest TipRanks data, approximately 7.52% of SAB Biotherapeutics (SABS) stock is held by retail investors.
Who owns the most shares of SAB Biotherapeutics (SABS)?
Joseph Edelman owns the most shares of SAB Biotherapeutics (SABS).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.